Skip to main content
Erschienen in: La radiologia medica 3/2016

01.03.2016 | ABDOMINAL RADIOLOGY

Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?

verfasst von: Francesco Giganti, Annalaura Salerno, Alessandro Ambrosi, Damiano Chiari, Elena Orsenigo, Antonio Esposito, Luca Albarello, Elena Mazza, Carlo Staudacher, Alessandro Del Maschio, Francesco De Cobelli

Erschienen in: La radiologia medica | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the role of the apparent diffusion coefficient (ADC) as a potential prognostic biomarker in the evaluation of the aggressiveness of oesophageal cancer.

Materials and methods

Between November 2009 and December 2013, 43 patients with evidence of oesophageal or oesophago-gastric junction cancer were referred to our institution and prospectively entered in our database. The final study population consisted of 23 patients (18 men; 5 women; mean age, 64.62 ± 10.91 years) who underwent diffusion-weighted Magnetic Resonance before surgical intervention. Specifically, 14 were directly treated with surgery and 9 were addressed to chemo/radiotherapy beforehand. Two radiologists independently measured mean tumour ADC and inter-observer agreement (Spearman’s and intraclass correlation coefficient [ICC]) was assessed. In the univariate analysis, overall survival curves related to pathological ADC, pT, pN, tumour location and histotype were fitted using the Kaplan–Meier method. Survival curves were then compared using the log-rank test.

Results

Inter-observer reproducibility was very good (Spearman’s rho = 0.95; ICC = 0.94). At a total median follow-up of 19 months (2–49 months), 4 patients had died. The median follow-up was 18.50 months (5–49 months) for the surgery-only group (1/4 events, 25 %) and 24 months (2–34 months) for the chemo/radiotherapy group (3/4 events, 75 %). Survival time at 48 months for the overall population was 59 % (±0.11), while for the surgery-only group and the chemo/radiotherapy group was 90 % (±0.09) and 61 % (±0.34), respectively. In the univariate analysis, ADC values below or equal to 1.4 × 10−3 mm2/s were associated with a negative prognosis both in the total population (P = 0.016) and in the surgery-only group (P < 0.001).

Conclusion

Despite the biggest limitation of our study (i.e. the small study population), we were able to show that pathological ADC could be considered a prognostic factor for oesophageal cancer. DWI might be introduced into clinical practice as a promising and reliable technique in the diagnostic pathway of this tumour.
Literatur
1.
Zurück zum Zitat Keighley MR (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18(Suppl 3):7–30CrossRefPubMed Keighley MR (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18(Suppl 3):7–30CrossRefPubMed
3.
Zurück zum Zitat Dhupar R, Correa AM, Ajani J et al (2014) Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770–776CrossRefPubMed Dhupar R, Correa AM, Ajani J et al (2014) Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770–776CrossRefPubMed
4.
Zurück zum Zitat Courrech Staal EF, Aleman BM, Boot H, van Velthuysen ML, van Tinteren H, van Sandick JW (2010) Systematic review of the benefits and risks of Neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97(10):1482–1496CrossRefPubMed Courrech Staal EF, Aleman BM, Boot H, van Velthuysen ML, van Tinteren H, van Sandick JW (2010) Systematic review of the benefits and risks of Neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97(10):1482–1496CrossRefPubMed
5.
Zurück zum Zitat Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta analysis. Lancet Oncol 12:681–692CrossRefPubMed Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta analysis. Lancet Oncol 12:681–692CrossRefPubMed
6.
Zurück zum Zitat Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared Neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543CrossRefPubMed Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared Neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543CrossRefPubMed
7.
Zurück zum Zitat Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168CrossRefPubMed Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168CrossRefPubMed
8.
Zurück zum Zitat Jamil LH, Gill KR, Wallace MB (2008) Staging and restaging of advanced esophageal cancer. Curr Opin Gastroenterol 24:530–534CrossRefPubMed Jamil LH, Gill KR, Wallace MB (2008) Staging and restaging of advanced esophageal cancer. Curr Opin Gastroenterol 24:530–534CrossRefPubMed
9.
Zurück zum Zitat Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421CrossRefPubMed Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421CrossRefPubMed
10.
Zurück zum Zitat Ishibashi Y, Hanyu N, Nakada K et al (2003) Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39:1409–1415CrossRefPubMed Ishibashi Y, Hanyu N, Nakada K et al (2003) Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39:1409–1415CrossRefPubMed
11.
Zurück zum Zitat Miyata H, Doki Y, Shiozaki H et al (2000) CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 6:4859–4865PubMed Miyata H, Doki Y, Shiozaki H et al (2000) CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 6:4859–4865PubMed
12.
Zurück zum Zitat Foley KG, Fielding P, Lewis WG et al (2014) Prognostic significance of novel 18F-FDG PET/CT defined tumour variables in patients with oesophageal cancer. Eur J Radiol 83(7):1069–1073CrossRefPubMed Foley KG, Fielding P, Lewis WG et al (2014) Prognostic significance of novel 18F-FDG PET/CT defined tumour variables in patients with oesophageal cancer. Eur J Radiol 83(7):1069–1073CrossRefPubMed
13.
Zurück zum Zitat Palie O, Michel P, Ménard JF et al (2013) The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imaging 40(9):1345–1355CrossRefPubMed Palie O, Michel P, Ménard JF et al (2013) The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imaging 40(9):1345–1355CrossRefPubMed
14.
Zurück zum Zitat De Cobelli F, Giganti F, Orsenigo E et al (2013) Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol 23(8):2165–2174CrossRefPubMed De Cobelli F, Giganti F, Orsenigo E et al (2013) Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol 23(8):2165–2174CrossRefPubMed
15.
Zurück zum Zitat Hein PA, Kremser C, Judmaier W et al (2013) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222CrossRef Hein PA, Kremser C, Judmaier W et al (2013) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222CrossRef
16.
Zurück zum Zitat Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199PubMedCentralCrossRefPubMed Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Sakurada A, Takahara T, Kwee TC et al (2009) Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19:1461–1469CrossRefPubMed Sakurada A, Takahara T, Kwee TC et al (2009) Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19:1461–1469CrossRefPubMed
18.
Zurück zum Zitat Aoyagi T, Shuto K, Okazumi S et al (2010) Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 1:847–852 Aoyagi T, Shuto K, Okazumi S et al (2010) Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 1:847–852
19.
Zurück zum Zitat Wang L, Han C, Zhu S et al (2014) Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of oesophageal carcinoma treatment. Oncol Res Treat 37(3):112–116CrossRefPubMed Wang L, Han C, Zhu S et al (2014) Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of oesophageal carcinoma treatment. Oncol Res Treat 37(3):112–116CrossRefPubMed
20.
Zurück zum Zitat Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28:25–27CrossRef Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28:25–27CrossRef
21.
Zurück zum Zitat Giganti F, Orsenigo E, Esposito A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed Giganti F, Orsenigo E, Esposito A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed
22.
Zurück zum Zitat Van Rossum PS, van Hillegersberg R, Lever FM et al (2013) Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? Eur Radiol 23(7):1753–1765CrossRefPubMed Van Rossum PS, van Hillegersberg R, Lever FM et al (2013) Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? Eur Radiol 23(7):1753–1765CrossRefPubMed
23.
Zurück zum Zitat Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed
24.
Zurück zum Zitat Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed
25.
Zurück zum Zitat Hasegawa S, Yoshikawa T, Aoyama T et al (2013) Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma. Ann Surg Oncol 20(3):773–779CrossRefPubMed Hasegawa S, Yoshikawa T, Aoyama T et al (2013) Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma. Ann Surg Oncol 20(3):773–779CrossRefPubMed
26.
Zurück zum Zitat Giganti F, De Cobelli F, Canevari C et al (2014) Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging 40(5):1147–1157CrossRefPubMed Giganti F, De Cobelli F, Canevari C et al (2014) Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging 40(5):1147–1157CrossRefPubMed
27.
Zurück zum Zitat Riddell AM, Hillier J, Brown G et al (2006) Potential of surface-coil MRI for staging of esophageal cancer. AJR Am J Roentgenol 187(5):1280–1287CrossRefPubMed Riddell AM, Hillier J, Brown G et al (2006) Potential of surface-coil MRI for staging of esophageal cancer. AJR Am J Roentgenol 187(5):1280–1287CrossRefPubMed
28.
Zurück zum Zitat Dave UR, Williams AD, Wilson JA et al (2004) Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 230(1):281–286CrossRefPubMed Dave UR, Williams AD, Wilson JA et al (2004) Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 230(1):281–286CrossRefPubMed
29.
Zurück zum Zitat Jeh SK, Kim SH, Kim HS et al (2011) Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 33(1):102–109CrossRefPubMed Jeh SK, Kim SH, Kim HS et al (2011) Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 33(1):102–109CrossRefPubMed
30.
Zurück zum Zitat Imanishi S, Shuto K, Aoyagi T, Kono T, Saito H, Matsubara H (2013) Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma. Dig Sug 30:240–248CrossRef Imanishi S, Shuto K, Aoyagi T, Kono T, Saito H, Matsubara H (2013) Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma. Dig Sug 30:240–248CrossRef
Metadaten
Titel
Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
verfasst von
Francesco Giganti
Annalaura Salerno
Alessandro Ambrosi
Damiano Chiari
Elena Orsenigo
Antonio Esposito
Luca Albarello
Elena Mazza
Carlo Staudacher
Alessandro Del Maschio
Francesco De Cobelli
Publikationsdatum
01.03.2016
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 3/2016
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-015-0585-2

Weitere Artikel der Ausgabe 3/2016

La radiologia medica 3/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.